Annovis Bio Inc. (ANVS) NYSE MKT LLC

$29.20 1.21 (4.32%)

Market Cap: $226.73M

As of 10/18/21 04:00 PM EDT. Market closed.

(ANVS)

Annovis Bio Inc. (ANVS) NYSE MKT LLC

$29.20 1.21 (4.32%)

Market Cap: $226.73M

As of 10/18/21 04:00 PM EDT. Market closed.

Headquartered in Berwyn, Pennsylvania, Annovis Bio, Inc. (Annovis) is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease (AD), Parkinson's disease (PD) and Alzheimer's in Down Syndrome (AD-DS). The Comapny's believes that it is the only company developing a drug for AD, PD and AD-DS that inhibits more than one neurotoxic protein and, thereby, ... read more

Headquartered in Berwyn, Pennsylvania, Annovis Bio, Inc. (Annovis) is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease (AD), Parkinson's disease (PD) and Alzheimer's in Down Syndrome (AD-DS). The Comapny's believes that it is the only company developing a drug for AD, PD and AD-DS that inhibits more than one neurotoxic protein and, thereby, improves the information highway of the nerve cell, known as axonal transport. When this information flow is impaired, the nerve cell gets sick and dies. The Company expects its treatment to improve memory loss and dementia associated with AD and AD-DS, as well as body and brain function in PD. The Company has two ongoing Phase 2a studies: one in AD patients and one in both AD and PD patients. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Maria Maccecchini
Full Time Employees
2
URL
Address
1055 Westlakes Dr Ste 300, Pennsylvania, Berwyn, 19312-2410.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Maria Maccecchini
Full Time Employees
2
Address
1055 Westlakes Dr Ste 300, Pennsylvania, Berwyn, 19312-2410.
KEY STATS
Open
$29.19
Previous Close
$27.99
Days Range
$28.38 - $30.27
52 week range
$4.14 - $132
Volume
189,828
Avg. Volume (30 days)
270,889
Market Cap
$226.73M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
8,100,570
Open
$29.19
Previous Close
$27.99
Days Range
$28.38 - $30.27
52 week range
$4.14 - $132
Volume
189,828
Avg. Volume (30 days)
270,889
Market Cap
$226.73M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
8,100,570

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ANNOVIS BIO INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Bruck Claudine Director Oct 11, 2021 Buy $27.66 181 5,006 6,067 Oct 13, 2021, 04:03 PM
White Mark K. Director Oct 12, 2021 Buy $27.40 5,000 137,000 56,177 Oct 13, 2021, 04:02 PM
Maccecchini Maria-Luisa PRESIDENT AND CEO Oct 11, 2021 Buy $27.61 18,000 496,980 976,775 Oct 13, 2021, 04:00 PM
McCarthy Reid Director Aug 19, 2021 Buy $37.61 500 18,805 6,829 Aug 23, 2021, 11:36 AM
Hoffman Michael B Director Jan 31, 2020 Option Exercise $4.80 55,884 268,243 1,400,175 Feb 05, 2020, 06:05 AM
Hoffman Michael B Director Jan 31, 2020 Buy $6.00 33,333 199,998 47,619 Feb 05, 2020, 06:05 AM
Whelan, Jr. Robert M. Director Jan 31, 2020 Option Exercise $4.80 11,176 53,645 95,700 Feb 05, 2020, 06:05 AM
Whelan, Jr. Robert M. Director Jan 31, 2020 Buy $6.00 25,000 150,000 25,000 Feb 05, 2020, 06:05 AM
Bruck Claudine Director Jan 31, 2020 Option Exercise $4.80 1,117 5,362 5,886 Feb 05, 2020, 06:04 AM
Bruck Claudine Director Jan 31, 2020 Buy $6.00 800 4,800 800 Feb 05, 2020, 06:04 AM
Maccecchini Maria-Luisa President and CEO Jan 31, 2020 Buy $6.00 1,600 9,600 207,942 Feb 05, 2020, 06:03 AM
McGroarty Jeffrey Brian Chief Financial Officer Feb 03, 2020 Buy $7.15 19,500 139,428 52,833 Feb 05, 2020, 06:03 AM
McGroarty Jeffrey Brian Chief Financial Officer Jan 31, 2020 Buy $6.00 33,333 199,998 33,333 Feb 05, 2020, 06:03 AM
White Mark K. Director Jan 31, 2020 Option Exercise $4.80 3,252 15,610 51,177 Feb 05, 2020, 06:02 AM
White Mark K. Director Jan 31, 2020 Buy $6.00 1,734 10,404 1,734 Feb 05, 2020, 06:02 AM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Bruck Claudine Director 10/11/2021 5,006
White Mark K. Director 10/12/2021 137,000
Maccecchini Maria-Luisa PRESIDENT AND CEO 10/11/2021 496,980
McCarthy Reid Director 08/19/2021 18,805
Hoffman Michael B Director 01/31/2020 268,243
Hoffman Michael B Director 01/31/2020 199,998
Whelan, Jr. Robert M. Director 01/31/2020 53,645
Whelan, Jr. Robert M. Director 01/31/2020 150,000
Bruck Claudine Director 01/31/2020 5,362
Bruck Claudine Director 01/31/2020 4,800
Maccecchini Maria-Luisa President and CEO 01/31/2020 9,600
McGroarty Jeffrey Brian Chief Financial Officer 02/03/2020 139,428
McGroarty Jeffrey Brian Chief Financial Officer 01/31/2020 199,998
White Mark K. Director 01/31/2020 15,610
White Mark K. Director 01/31/2020 10,404
Load More Insider Transactions